Geoffrey Ku, MD - Fortifying the Framework for HER2+ GI Cancers: Precision Treatment Planning With Molecularly Targeted Therapies in GC/GEJC, CRC, and BTC

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/XJJ865. CME/MOC/CE/AAPA/IPCE credit will be available until February 24, 2026.

Fortifying the Framework for HER2+ GI Cancers: Precision Treatment Planning With Molecularly Targeted Therapies in GC/GEJC, CRC, and BTC

In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Support
This activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.

Disclosure information is available at the beginning of the video presentation.